GIANNELLA, MADDALENA
 Distribuzione geografica
Continente #
NA - Nord America 8.353
EU - Europa 6.647
AS - Asia 2.939
AF - Africa 309
SA - Sud America 64
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 6
Totale 18.359
Nazione #
US - Stati Uniti d'America 8.317
IT - Italia 2.008
GB - Regno Unito 1.595
SE - Svezia 935
SG - Singapore 931
CN - Cina 899
DE - Germania 674
VN - Vietnam 499
IN - India 347
IE - Irlanda 281
FR - Francia 234
RU - Federazione Russa 204
BG - Bulgaria 123
ZA - Sudafrica 103
EE - Estonia 96
CI - Costa d'Avorio 94
UA - Ucraina 86
CH - Svizzera 83
FI - Finlandia 81
TG - Togo 66
ID - Indonesia 58
JO - Giordania 54
NL - Olanda 52
ES - Italia 45
BE - Belgio 43
AU - Australia 39
NG - Nigeria 35
CA - Canada 26
PE - Perù 20
AT - Austria 19
JP - Giappone 18
HK - Hong Kong 16
IR - Iran 16
BR - Brasile 15
KR - Corea 15
TR - Turchia 15
PL - Polonia 14
RO - Romania 14
HR - Croazia 13
AR - Argentina 12
BD - Bangladesh 11
GR - Grecia 11
MY - Malesia 10
PH - Filippine 9
CL - Cile 8
SA - Arabia Saudita 7
DK - Danimarca 6
CZ - Repubblica Ceca 5
PK - Pakistan 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
LB - Libano 4
MK - Macedonia 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EU - Europa 3
HN - Honduras 3
HU - Ungheria 3
MX - Messico 3
PA - Panama 3
SC - Seychelles 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
EC - Ecuador 2
IL - Israele 2
LT - Lituania 2
LY - Libia 2
MM - Myanmar 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CO - Colombia 1
FK - Isole Falkland (Malvinas) 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
NO - Norvegia 1
SN - Senegal 1
TW - Taiwan 1
Totale 18.359
Città #
Southend 1.452
Fairfield 1.018
Singapore 819
Chandler 794
Ashburn 659
Woodbridge 474
Santa Clara 459
Wilmington 436
Seattle 414
Houston 394
Cambridge 360
Princeton 324
Ann Arbor 311
Bologna 292
Boardman 282
Dublin 280
Dong Ket 204
New York 137
Milan 128
Rome 128
Sofia 119
Berlin 114
Westminster 112
Nanjing 101
Abidjan 94
Padova 94
Saint Petersburg 75
Bern 67
Lomé 66
San Diego 62
Redmond 61
Beijing 60
Helsinki 60
Falls Church 59
Turin 57
Bremen 55
Amman 54
Florence 54
Jakarta 54
Shenyang 53
Jinan 51
Brussels 38
Hebei 38
Dearborn 35
Nanchang 35
Abeokuta 34
Redwood City 33
Guangzhou 32
Shanghai 32
Des Moines 30
Olalla 29
Jiaxing 25
Boydton 24
Changsha 24
Genoa 23
Los Angeles 23
Amsterdam 22
Paris 22
Parma 22
San Francisco 22
Tianjin 22
Catania 21
Washington 21
Chicago 19
Zhengzhou 19
Lappeenranta 18
Lima 18
London 18
Bühl 17
Norwalk 17
Tappahannock 17
Naples 16
Palermo 15
Reggio Emilia 15
Shenzhen 15
Duncan 14
Ningbo 14
Toronto 14
Vienna 14
Hong Kong 13
Medford 13
Sala Bolognese 12
Modena 11
Mountain View 11
São Paulo 11
Adelaide 10
Budrio 10
Cava De' Tirreni 10
Hangzhou 10
Hyderabad 10
Kuala Lumpur 10
Leganés 10
Mumbai 10
Pisa 10
Rimini 10
Taizhou 10
Verona 10
Warsaw 10
Wuhan 10
Bergamo 9
Totale 11.974
Nome #
Caratterizzazione fenotipica e genotipica di ceppi di Staphylococcus aureus isolati in corso di batteriemia 602
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 515
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 195
Infectious meningitis/encephalitis: evaluation of a rapid and fully automated multiplex PCR in the microbiological diagnostic workup 194
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa ? 193
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 179
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 179
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 174
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 171
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 164
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 158
Bloodstream infections in patients with liver cirrhosis 153
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 147
Advances in the therapy of bacterial bloodstream infections 145
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 142
Impact of preoperative infection on outcome after liver transplantation 140
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 139
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 138
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 134
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 133
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 132
Invasive candidiasis due to candida norvegensis in a liver transplant patient: Case report and literature review 132
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 132
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 132
Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program 131
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 131
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 130
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 130
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 122
Candida tropicalis fungaemia: Incidence, risk factors and mortality in a general hospital 121
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 119
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 119
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 118
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 117
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 117
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 116
Comparison of real-time RT-PCR, shell vial culture, and conventional cell culture for the detection of the pandemic influenza A (H1N1) in hospitalized patients 116
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 116
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection 115
The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts 114
Diffuse primary cutaneous infection by Alternaria alternata in a liver transplant recipient with pulmonary nocardiosis: Importance of prompt identification for clinical resolution 114
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 113
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 113
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 113
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 112
Adaptive trials of new antimicrobials for infections with carbapenem-resistant, Gram-negative bacteria 110
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: A prospective six-year experience 110
Use of Daptomycin in Critically Ill Children with Bloodstream Infections and Complicated Skin and Soft-tissue Infections 107
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 106
Pneumonia treated in the internal medicine department: Focus on healthcare-associated pneumonia 105
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 105
Genotyping of a nosocomial outbreak of pandemic influenza A/H1N1 2009 104
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 104
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians 103
Targeted antifungal prophylaxis in heart transplant recipients 103
Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit 103
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing 103
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction 103
Two weeks of postsurgical therapy may be enough for high-risk cases of endocarditis caused by Streptococcus viridans or Streptococcus bovis 102
null 102
Teicoplanin use and emergence of Staphylococcus haemolyticus: Is there a link? [1] 102
Management of intra-abdominal infections: Recommendations by the WSES 2016 consensus conference 101
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study 101
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 101
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 101
Diagnosis of influenza in intensive care units: lower respiratory tract samples are better than nose-throat swabs 100
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 100
A painful hand in a kidney transplant recipient 99
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 99
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 99
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 99
Herpes simplex virus: A marker of severity in bacterial ventilator-associated pneumonia 98
Clinical experience of colistin-glycopeptide combination in critically ill patients infected with gram-negative bacteria 98
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 98
Opportunistic infections in end stage liver disease 97
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 96
The management of pneumonia in internal medicine 96
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 96
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 94
Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases 93
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 93
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 93
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 93
Incidence and risk factors for ventilator-associated pneumonia after major heart surgery 92
Predictors of mortality in multidrug-resistantKlebsiella pneumoniaebloodstream infections 92
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 91
High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality 91
Cryptococcal meningitis in a patient treated with infliximab 91
Conservative medical therapy of prosthetic joint infections: Retrospective analysis of an 8-year experience 91
null 91
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 91
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis 91
Serum Galactomannan Diagnosis of Breakthrough Invasive Fungal Disease 90
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data 90
Potential protective role of linezolid against Clostridium difficile infection 90
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis 90
Reply: Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 90
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 90
null 90
How much European prescribing physicians know about invasive fungal infections management? 89
Totale 12.377
Categoria #
all - tutte 55.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.712 0 0 0 0 342 364 453 559 470 223 105 196
2020/20212.438 324 205 92 69 229 92 86 140 212 173 141 675
2021/20223.339 228 100 160 269 272 208 124 276 172 386 547 597
2022/20233.853 341 423 203 504 360 309 142 258 692 175 239 207
2023/20242.071 149 245 157 191 172 328 157 138 92 165 125 152
2024/20252.920 246 767 543 577 787 0 0 0 0 0 0 0
Totale 19.028